Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

A multimeric immunogen for the induction of immune memory to beta-amyloid.

Mantile F, Basile C, Cicatiello V, De Falco D, Caivano A, De Berardinis P, Prisco A.

Immunol Cell Biol. 2011 Jul;89(5):604-9. doi: 10.1038/icb.2010.134. Epub 2010 Nov 23.

PMID:
21102534
2.

Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.

Chackerian B, Rangel M, Hunter Z, Peabody DS.

Vaccine. 2006 Sep 11;24(37-39):6321-31. Epub 2006 Jun 6.

PMID:
16806604
3.

Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.

Xing XN, Zhang WG, Sha S, Li Y, Guo R, Wang C, Cao YP.

Chin Med J (Engl). 2011 Sep;124(17):2636-41.

PMID:
22040416
4.

Short amyloid-β immunogens with spacer-enhanced immunogenicity without junctional epitopes for Alzheimer's disease immunotherapy.

Guan X, Zou J, Gu H, Yao Z.

Neuroreport. 2012 Oct 24;23(15):879-84. doi: 10.1097/WNR.0b013e328358a044.

PMID:
22922658
5.

Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.

Yu YZ, Wang S, Bai JY, Zhao M, Chen A, Wang WB, Chang Q, Liu S, Qiu WY, Pang XB, Xu Q, Sun ZW.

Clin Immunol. 2013 Oct;149(1):11-24. doi: 10.1016/j.clim.2013.05.016. Epub 2013 Jun 5.

PMID:
23886550
7.

Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.

Liu S, Shi D, Wang HC, Yu YZ, Xu Q, Sun ZW.

Sci Rep. 2015 Jan 14;5:7771. doi: 10.1038/srep07771.

8.

Aβ-HBc virus-like particles immunization without additional adjuvant ameliorates the learning and memory and reduces Aβ deposit in PDAPP mice.

Jin H, Wang W, Zhao S, Yang W, Qian Y, Jia N, Feng G.

Vaccine. 2014 Jul 31;32(35):4450-6. doi: 10.1016/j.vaccine.2014.06.051. Epub 2014 Jun 21.

PMID:
24962758
9.

Species-specific immune response to immunization with human versus rodent A beta peptide.

Seabrook TJ, Bloom JK, Iglesias M, Spooner ET, Walsh DM, Lemere CA.

Neurobiol Aging. 2004 Oct;25(9):1141-51.

PMID:
15312960
10.

Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.

Maier M, Seabrook TJ, Lemere CA.

Neurodegener Dis. 2005;2(5):267-72. Review.

PMID:
16909008
11.

Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease.

Fu L, Li Y, Hu Y, Yu B, Zhang H, Wu J, Wu H, Yu X, Kong W.

Immunol Lett. 2015 Nov;168(1):22-30. doi: 10.1016/j.imlet.2015.09.002. Epub 2015 Sep 5.

PMID:
26349054
12.

Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.

Nemirovsky A, Fisher Y, Baron R, Cohen IR, Monsonego A.

Vaccine. 2011 May 23;29(23):4043-50. doi: 10.1016/j.vaccine.2011.03.033. Epub 2011 Apr 5.

PMID:
21473952
13.

Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.

Axelsen TV, Holm A, Christiansen G, Birkelund S.

Vaccine. 2011 Apr 12;29(17):3260-9. doi: 10.1016/j.vaccine.2011.02.026. Epub 2011 Mar 1.

PMID:
21371581
14.

Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.

Dodel R, Balakrishnan K, Keyvani K, Deuster O, Neff F, Andrei-Selmer LC, Röskam S, Stüer C, Al-Abed Y, Noelker C, Balzer-Geldsetzer M, Oertel W, Du Y, Bacher M.

J Neurosci. 2011 Apr 13;31(15):5847-54. doi: 10.1523/JNEUROSCI.4401-10.2011.

15.

Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.

Feng G, Wang W, Qian Y, Jin H.

J Neurosci Methods. 2013 Aug 15;218(1):48-54. doi: 10.1016/j.jneumeth.2013.05.006. Epub 2013 May 20.

PMID:
23701997
16.

A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease.

Zhang J, Wu X, Qin C, Qi J, Ma S, Zhang H, Kong Q, Chen D, Ba D, He W.

Neurobiol Dis. 2003 Dec;14(3):365-79.

PMID:
14678754
17.
18.

Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.

Fernández IM, Snijders A, Benaissa-Trouw BJ, Harmsen M, Snippe H, Kraaijeveld CA.

J Virol. 1993 Oct;67(10):5843-8.

19.
20.

Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.

Seabrook TJ, Iglesias M, Bloom JK, Spooner ET, Lemere CA.

Vaccine. 2004 Sep 28;22(29-30):4075-83.

PMID:
15364459

Supplemental Content

Support Center